Yating Cheng

Yating Cheng

Auto-generated profile, based on publicly available information

Yating Cheng

Laboratory Diagnosis Department Guangzhou Kingmed Center for Clinical Laboratory Guangzhou China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

3 December 2020 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Open access
PDF file
RTRan Tao
Ran Tao
CZChenli Zhang
Chenli Zhang
MLMin Liu
Min Liu
MYMiao Yang
Miao Yang
WGWenying Gao
Wenying Gao
QXQin Xie
Qin Xie
Background: Verification of new reagent lots is a part of the crucial tasks in clinical laboratories. The Clinical and Laboratory Standards Institute (CLSI) EP26‐A guideline provides laboratories with an evaluation method for reagent verification. The purpose of this study was to compare the performance of EP26‐A with our laboratory reagent lot verification protocol and get the final scheme.Method: 16 chemiluminescence analytes including estradiol (E2), progesterone (P), ferritin (FER), cortisol (COR),carbohydrate antigen 153 (CA153), and free prostate‐specific antigen (FPSA). were prospectively evaluated in two reagent lots. The laboratory's lot verification process included evaluating 5 patient samples with the current and new lots and acceptability according to a predefined criteria. For EP26‐A, method imprecision data and critical differences at medical decision points were important factors affecting the sample size requirements and rejection limits.Result: The number of samples required for EP26‐A was 3 to 12, of which P, CA153, and FPSA had increased by more than 5 samples compared with the current protocol. Of the 16 chemiluminescence analytes, 11 had higher rejection limits when using EP26‐A than the current laboratory scheme. Our current protocol and EP26‐A were in agreement in 32 of the 32 (100%) paired verifications.Conclusion: The EP26‐A protocol is an important tool to find the differences between reagent lots, and it makes up for the loopholes in the statistical efficiency, sample concentration and quantity, and the selection of rejection limits in the current protocol.

3 April 2023
Verified
Other
Open access
ALAlexandra Lacey
Alexandra Lacey
EHErik Hedrick
Erik Hedrick
YCYating Cheng
Yating Cheng
KMKumaravel Mohankumar
Kumaravel Mohankumar
MWMelanie Warren
Melanie Warren
Stephen H. SafeStephen H. Safe
Stephen H. Safe

3 April 2023
Verified
Other
Open access
ALAlexandra Lacey
Alexandra Lacey
EHErik Hedrick
Erik Hedrick
YCYating Cheng
Yating Cheng
KMKumaravel Mohankumar
Kumaravel Mohankumar
MWMelanie Warren
Melanie Warren
Stephen H. SafeStephen H. Safe
Stephen H. Safe
(A) IPA analysis of pathways observed after knockdown of PAX3-FOXO1 in Rh30 cells. (B.) Knockdown of NR4A1 in ARMS cells by a second oligonucleotide targeting NR4A1.

3 April 2023
Verified
Other
Open access
ALAlexandra Lacey
Alexandra Lacey
EHErik Hedrick
Erik Hedrick
YCYating Cheng
Yating Cheng
KMKumaravel Mohankumar
Kumaravel Mohankumar
MWMelanie Warren
Melanie Warren
Stephen H. SafeStephen H. Safe
Stephen H. Safe

3 April 2023
Verified
Other
Open access
ALAlexandra Lacey
Alexandra Lacey
EHErik Hedrick
Erik Hedrick
YCYating Cheng
Yating Cheng
KMKumaravel Mohankumar
Kumaravel Mohankumar
MWMelanie Warren
Melanie Warren
Stephen H. SafeStephen H. Safe
Stephen H. Safe
The effects of transfection of ARMS cells with siIL24